Autopsy report · NCT00587457
A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia
Cause of deathOther
“The study is terminated early due to unavailability of investigational product.”
Life of this trial
- Registered 9 months after it had already started.
- Ran for about 1 year 1 month before it stopped.
- 11 participants enrolled.
- Results were posted on the registry 9 years after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- MedImmune LLC
- Sponsor type
- Industry
- Conditions
- Leukemia, Lymphoma, Chronic Lymphocytic; Leukemia, Prolymphocytic Leukemia, Small; Lymphocytic Lymphoma, Moxetumomab Pasudotox
- Interventions
- CAT-8015 5 mcg/kg; CAT-8015 10 mcg/kg; CAT-8015 20 mcg/kg
- Participants
- 11
- Sites
- 3
- Countries
- Poland, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.